Gastric neuroendocrine carcinoma associated with chronic atrophic gastritis type A

被引:15
|
作者
Kaizaki, Y
Fujii, T
Kawai, T
Saito, K
Kurihara, K
Fukayama, M
机构
[1] Department of Pathology, Jichi Medical School, Kawachi-gun, Tochigi 329-04, Yakushiji, Minamikawachi-machi
[2] Department of General Surgery, Jichi Medical School, Kawachi-gun, Tochigi 329-04, Yakushiji, Minamikawachi-machi
关键词
gastric neuroendocrine carcinoma; chronic atrophic gastritis type A (GAG/A); gastric carcinoid tumor; neuroendocrine cell micronest (NECM);
D O I
10.1007/BF02934114
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We report a case of gastric neuroendocrine (NE) carcinoma associated with chronic atrophic gastritis type A (CAG/A) or reversed atrophic type gastritis. A 9 x 6 cm tumor was resected from the stomach to control pain in a 55-year-old Japanese woman with peritoneal dissemination and metastatic tumors of the liver and ovary. Histologically, the tumor was NE carcinoma which showed an organoid structure, but consisted of NE cells with overt cytological atypia and frequent mitotic activity. Multiple microcarcinoids and NE cell micronests (NECMs) were also observed in the atrophic non-neoplastic mucosa of the gastric body. CEA immunoreactivity and a high Ki-67 labeling index were characteristic features of the neoplastic NE cells of the carcinoma. Although most NE tumors arising from CAG/A are typical carcinoid tumors, the present case illustrates that a high-grade NE carcinoma can develop from diverse NE cell proliferation in association with CAG/A.
引用
收藏
页码:643 / 649
页数:7
相关论文
共 40 条
  • [31] Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma
    Hualong Zheng
    YaJun Zhao
    Qingliang He
    Hankun Hao
    Yantao Tian
    Bingbing Zou
    Lixin Jiang
    Xiantu Qiu
    Yanbing Zhou
    Zhi Li
    Yanchang Xu
    Gang Zhao
    Fangqin Xue
    Shuliang Li
    Weihua Fu
    Yongxiang Li
    Xiaojun Zhou
    Yong Li
    Zhenggang Zhu
    Jinping Chen
    Zekuan Xu
    Lisheng Cai
    En Li
    Honglang Li
    Jianwei Xie
    Chaohui Zheng
    Jun Lu
    Ping Li
    Changming Huang
    Gastric Cancer, 2021, 24 : 503 - 514
  • [32] Gastric large cell neuroendocrine carcinoma with venous tumor thrombus: the value of PET/CT and contrast-enhanced computed tomography
    Song, Le
    Jin, Zhu
    Zhang, Weifang
    Zhang, Yanyan
    CLINICAL IMAGING, 2015, 39 (02) : 325 - 328
  • [33] Systemic chemotherapy with pronounced efficacy and neutropenia in a granulocyte-colony stimulating factor-producing advanced gastric neuroendocrine carcinoma
    Tsuruta, Nobuhiro
    Takayoshi, Kotoe
    Arita, Shuji
    Aikawa, Tomomi
    Ariyama, Hiroshi
    Kusaba, Hitoshi
    Ohuchida, Kenoki
    Nagai, Eishi
    Kohashi, Kenichi
    Hirahashi, Minako
    Inadomi, Kyoko
    Tanaka, Mamoru
    Sagara, Kosuke
    Okumura, Yuta
    Nio, Kenta
    Nakano, Michitaka
    Nakamura, Masafumi
    Oda, Yoshinao
    Akashi, Koichi
    Baba, Eishi
    ONCOLOGY LETTERS, 2017, 14 (02) : 1500 - 1504
  • [34] Risk factors for metastasis and survival of patients with T1 gastric neuroendocrine carcinoma treated with endoscopic therapy versus surgical resection
    Hua Ye
    Yuan Yuan
    Ping Chen
    Qi Zheng
    Surgical Endoscopy, 2022, 36 (8) : 6162 - 6169
  • [35] CDK5RAP3 inhibits angiogenesis in gastric neuroendocrine carcinoma by modulating AKT/HIF-1α/VEGFA signaling
    Lin, Jian-Xian
    Weng, Xiong-Feng
    Xie, Xin-Sheng
    Lian, Ning-Zi
    Qiu, Sheng-Liang
    Wang, Jia-Bin
    Lu, Jun
    Chen, Qi-Yue
    Cao, Long-Long
    Lin, Mi
    Tu, Ru-Hong
    Yang, Ying-Hong
    Liu, Si-Jia
    Hu, Min
    Lin, Yi-Ke
    Huang, Chang-Ming
    Zheng, Chao-Hui
    Li, Ping
    Xie, Jian-Wei
    CANCER CELL INTERNATIONAL, 2019, 19 (01)
  • [36] CDK5RAP3 inhibits angiogenesis in gastric neuroendocrine carcinoma by modulating AKT/HIF-1α/VEGFA signaling
    Jian-Xian Lin
    Xiong-Feng Weng
    Xin-Sheng Xie
    Ning-Zi Lian
    Sheng-Liang Qiu
    Jia-Bin Wang
    Jun Lu
    Qi-Yue Chen
    Long-Long Cao
    Mi Lin
    Ru-Hong Tu
    Ying-Hong Yang
    Si-Jia Liu
    Min Hu
    Yi-Ke Lin
    Chang-Ming Huang
    Chao-Hui Zheng
    Ping Li
    Jian-Wei Xie
    Cancer Cell International, 19
  • [37] Risk factors for metastasis and survival of patients with T1 gastric neuroendocrine carcinoma treated with endoscopic therapy versus surgical resection
    Ye, Hua
    Yuan, Yuan
    Chen, Ping
    Zheng, Qi
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2022, 36 (08): : 6162 - 6169
  • [38] Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma
    Yamashita, Satoshi
    Abe, Hiroyuki
    Kunita, Akiko
    Yamashita, Hiroharu
    Seto, Yasuyuki
    Ushiku, Tetsuo
    HISTOPATHOLOGY, 2021, 78 (03) : 381 - 391
  • [39] Predictive Value of Combined Preoperative Carcinoembryonic Antigen Level and Ki-67 Index in Patients With Gastric Neuroendocrine Carcinoma After Radical Surgery
    Xie, Jianwei
    Zhao, YaJun
    Zhou, Yanbing
    He, Qingliang
    Hao, Hankun
    Qiu, Xiantu
    Zhao, Gang
    Xu, Yanchang
    Xue, Fangqin
    Chen, Jinping
    Su, Guoqiang
    Li, Ping
    Zheng, Chao-Hui
    Huang, Chang-Ming
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] Gastric neuroendocrine carcinoma with positive staining for prostate cancer markers including prostate-specific antigen and alpha-methylacyl-CoA racemase
    Hakozaki, Yuji
    Murata, Taro
    Yokoyama, Munehiro
    Matsushima, Hisashi
    Ogawa, Maki
    Masuda, Tomoko
    Hirai, Yoko
    Kume, Haruki
    UROLOGY CASE REPORTS, 2018, 20 : 67 - 69